Soleno Therapeutics (SLNO) Profit After Tax Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.65% |
| Dec 31, 2025 | 76.68% |
| Sep 30, 2025 | 38.22% |
| Jun 30, 2025 | 8.61% |
| Mar 31, 2025 | -49.52% |
| Dec 31, 2024 | -30.79% |
| Sep 30, 2024 | -144.95% |
| Jun 30, 2024 | -16.91% |
| Mar 31, 2024 | -24.93% |
| Dec 31, 2023 | -114.07% |
| Sep 30, 2023 | -36.30% |
| Jun 30, 2023 | -3.73% |
| Mar 31, 2023 | -17.04% |
| Dec 31, 2022 | 6.78% |
| Sep 30, 2022 | -19.73% |
| Jun 30, 2022 | -17.09% |
| Mar 31, 2022 | -22.86% |
| Dec 31, 2021 | -14.75% |
| Sep 30, 2021 | -35.58% |
| Jun 30, 2021 | -25.62% |
| Mar 31, 2021 | -22.93% |
| Dec 31, 2020 | -0.05% |
| Sep 30, 2020 | -21.01% |
| Jun 30, 2020 | -42.74% |
| Mar 31, 2020 | 12.85% |
| Dec 31, 2019 | -15.17% |
| Sep 30, 2019 | 18.85% |
| Jun 30, 2019 | -29.08% |
| Mar 31, 2019 | -53.16% |
| Dec 31, 2018 | 17.82% |
| Sep 30, 2018 | -7.75% |